AbbVie Inc. — Director's Dealing 2021

Aug 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2021-08-23

Reporting Person: Sorg Elaine K. (SVP, US Commercial Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-23	Common Stock, $0.01 par value	S	6000	$120	Disposed	11595	Direct
2021-08-23	Common Stock, $0.01 par value	M	7080	$114.36	Acquired	18675	Direct
2021-08-23	Common Stock, $0.01 par value	S	7080	$120	Disposed	11595	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-23	Option (Right to buy)	$114.36	M	7080	Disposed	2028-02-14	Common Stock (7080)	Direct

Footnotes

F1: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.